Sales and Marketing

Showing 15 posts of 11524 posts found.

shigella

Hilleman labs partners with Indian Government for shigella vaccine

April 11, 2017 Manufacturing and Production, Sales and Marketing NICED, hilleman, shigella

India’s Hilleman Laboratories and the National Institute of Cholera and Enteric Diseases (NICED) are set to develop and market a …
embotrap

J&J acquires Neuravi to bolster neuro business

April 11, 2017 Manufacturing and Production, Sales and Marketing Johnson & Johnson, Neuravi

Johnson & Johnson’s neurosurgery and neurovascular unit, Codman Neuro, has made the move to acquire Galway-based company, Neuravi. The exact …
janssen_latest_logo_on_sign_closer

Scotland recommends Janssen’s Imbruvica for leukaemia

April 11, 2017 Manufacturing and Production, Sales and Marketing SMC, imbruvica, leukaemia

Janssen has been celebrating the news that its Imbruvica (ibrutinib) has been recommended by the Scottish Medicines Consortium (SMC) for …
opdivo_1_1

NICE turns down BMS’ Opdivo for head and neck cancer

April 11, 2017 Manufacturing and Production, Sales and Marketing BMS, NICE, opdivo

Bad news for Bristol-Myers Squibb as NICE chooses not to recommend its immunotherapy drug Opdivo (nivolumab) for use in head …

Bioverativ installs new EVP of R&D

April 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bioverativ

Bioverativ, a biotech company that develops therapies for rare blood disorders, announced the appointment of Tim Harris as Executive Vice …
gilead-sciences

FDA approves first two antiviral hep C drugs for paediatric patients

April 10, 2017 Sales and Marketing FDA, harvoni, hepatitis C, sovaldi

The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi (sofosbuvir) …
human-ear-1462020301zmm

Virus fixes DNA mutations for possible hearing loss therapy

April 10, 2017 Research and Development, Sales and Marketing Ear, deafblindness, hearing loss, inner hair

Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …
actelion

EMA green lights Actelion’s drug after patient deaths scare

April 10, 2017 Sales and Marketing Actelion, Johnson & Johnson, Uptravi

The EMA has ruled that the five patient deaths that occurred in February of this year were not directly related …
roche_dark_0

Roche’s lung cancer drug beats Pfizer rival in study

April 10, 2017 Research and Development, Sales and Marketing Alecensa, Roche

Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing …

Fresenius confirms takeover talks with Akorn

April 10, 2017 Sales and Marketing Akorn, Fresenius

Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …
novartis_outside_1

Novartis takes on dry-eye market with drug in-licensing move

April 7, 2017 Medical Communications, Sales and Marketing Lubris, Novartis, dry eye

Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …

Faubel takes over RFID specialist SIL

April 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Faubel, Nachfolger

The Melsungen printer Faubel & Co. Nachfolger GmbH, which mainly produces booklet labels and custom labels for the pharmaceutical industry, …
johnson_and_johnson_jj

J&J ordered to pay $5m over false marketing claims

April 6, 2017 Sales and Marketing J&J, JJ, lawsuit

Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …
dna-163466_960_720

CRISPR: An up close and personal take on precision medicine

April 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRISR, Precision Medicine

Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …
The Gateway to Local Adoption Series

Latest content